Synergistic Systems for Enhanced Fluid Balance Monitoring and Control

Publication ID: 24-11857714_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Systems for Enhanced Fluid Balance Monitoring and Control,” Published Technical Disclosure No. 24-11857714_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857714_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,714.

Summary of the Inventive Concept

The present inventive concept integrates AI, IoT, blockchain, and new materials with biological fluid processing devices to create a more powerful system for monitoring and controlling fluid balance during medical procedures, enhancing patient safety and treatment outcomes.

Background and Problem Solved

The original patent disclosed systems and methods for monitoring and controlling fluid balance in medical procedures, but it had limitations in terms of real-time data analysis, patient data security, and fluid flow efficiency. The new inventive concept addresses these limitations by incorporating advanced technologies to provide a more comprehensive and effective solution.

Detailed Description of the Inventive Concept

The new system comprises a fluid circuit, a separation chamber, a treatment container, and an AI-powered controller that predicts and prevents fluid imbalances based on real-time data from IoT-enabled sensors. Additionally, the system integrates blockchain technology to securely store and track patient data and treatment protocols. The biological fluid processing device features a new material-based fluid conduit that enhances fluid flow and reduces contamination risk. The system also utilizes machine learning algorithms to analyze data from multiple sources and identify high-risk patients, optimizing treatment protocols.

Novelty and Inventive Step

The new claims introduce the novel combination of AI, IoT, blockchain, and new materials with biological fluid processing devices, providing a synergistic effect that enhances the overall system's performance and safety. The inventive step lies in the integration of these distinct technologies to create a more powerful and effective system for monitoring and controlling fluid balance.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations may also include the integration of additional technologies, such as robotic automation or virtual reality, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of blood processing, dialysis, and surgical procedures. The system's enhanced safety and efficiency features make it an attractive solution for hospitals, clinics, and medical research institutions.

CPC Classifications

SectionClassGroup
A A61 A61M1/3607
A A61 A61M1/0209
A A61 A61M1/361
A A61 A61M1/3643
A A61 A61M1/3672
A A61 A61M1/3683
A A61 A61M1/3693
A A61 A61M1/3696
A A61 A61M1/38
A A61 A61M2202/0092
A A61 A61M2202/0407
A A61 A61M2202/0413
A A61 A61M2202/0415
A A61 A61M2202/0429
A A61 A61M2202/0439
A A61 A61M2202/0443
A A61 A61M2205/3386
A A61 A61M2205/50
A A61 A61M2230/005
A A61 A61M2230/207

Field of Art

Medical fluid processing systems, specifically blood separation and treatment technologies involving complex fluid management devices with advanced control systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, fluid dynamics, control systems, and medical instrumentation, possessing advanced degrees and 5-7 years of professional experience in developing medical fluid processing technologies

Obviousness Rationale

A PHOSITA would recognize that integrating emerging technologies like AI, IoT, and blockchain into existing fluid processing systems represents a predictable technological evolution that addresses known limitations in medical device monitoring and data management. The fundamental fluid processing principles from the source patent provide a clear technological foundation that can be systematically enhanced with contemporary digital technologies. The proposed variations represent incremental improvements that would be obvious to a skilled practitioner seeking to optimize medical fluid processing systems.

Obvious Combinations & Variations

Source Patent Element
Biological fluid processing device with separation chamber and pump system for controlling fluid volumes
PTD Variation
Adding AI-powered controller with predictive analytics to monitor and prevent fluid imbalances
Obviousness Reasoning
Integrating intelligent control systems with existing medical devices is a known technique for improving precision and safety, representing a predictable technological enhancement
Source Patent Element
Fluid circuit with separation and treatment components
PTD Variation
Incorporating IoT-enabled sensors for real-time data collection and monitoring
Obviousness Reasoning
Augmenting medical devices with sensor networks is a standard approach for improving diagnostic capabilities and represents an obvious design optimization
Source Patent Element
Blood processing system with mechanical separation components
PTD Variation
Implementing blockchain technology for secure patient data tracking and protocol management
Obviousness Reasoning
Applying blockchain to medical device data management is a foreseeable solution to existing challenges in medical record integrity and traceability
Source Patent Element
Fluid processing device with standard fluid conduits
PTD Variation
Introducing new material-based fluid conduits to enhance flow characteristics and reduce contamination
Obviousness Reasoning
Material science improvements in medical device design represent a routine engineering approach to incremental device performance enhancement
Source Patent Element
Biological fluid processing control system
PTD Variation
Machine learning algorithms for analyzing multi-source data to identify high-risk treatment scenarios
Obviousness Reasoning
Applying advanced data analysis techniques to medical monitoring represents a logical and predictable technological progression
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857714 and the disclosed technological variations, a Person Having Ordinary Skill In The Art would find the proposed system enhancements obvious and lacking inventive step. The integration of AI, IoT, blockchain, and advanced materials into existing fluid processing technologies represents a predictable technological evolution that would be readily conceived by a skilled practitioner seeking to improve medical device performance and patient safety.

Original Patent Information

Patent NumberUS 11,857,714
TitleSystems and methods for monitoring and controlling fluid balance during a biological fluid procedure
Assignee(s)Fenwal, Inc.